ENSC 8-K: SEC filing
Ensysce Biosciences
Filed with the SEC on · accession 0001493152-26-051414
ENSC filed a 8-K (current report) with the SEC on Nov 12, 2026. Ensysce Biosciences reported Q3 2026 financial results, highlighting the completed acquisition of Cy Biopharma and its lead asset CY200 for CRPS, submission of a Phase 2a protocol to the UK MHRA, completion of enrollment in the PF614-MPAR-102 study, and a cash position of $29.7 million. The stock moved +8.4% by the first close after the filing.
Summary of the filing
Ensysce Biosciences reported Q3 2026 financial results, highlighting the completed acquisition of Cy Biopharma and its lead asset CY200 for CRPS, submission of a Phase 2a protocol to the UK MHRA, completion of enrollment in the PF614-MPAR-102 study, and a cash position of $29.7 million. The MHRA and ethics committee requested additional information on the CY200 Phase 2a application.
Key details
How ENSC stock reacted
Close before
$0.36
Nov 11, 2026
First close after
+8.44%
$0.39
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for ENSC, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ENSC?
Click hereFrequently asked questions
What did ENSC file with the SEC on Nov 12, 2026?
ENSC filed a 8-K (SEC filing). Ensysce Biosciences reported Q3 2026 financial results, highlighting the completed acquisition of Cy Biopharma and its lead asset CY200 for CRPS, submission of a Phase 2a protocol to the UK MHRA, completion of enrollment in the PF614-MPAR-102 study, and a cash position of $29.7 million. The MHRA and ethics committee requested additional information on the CY200 Phase 2a application.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did ENSC stock react to this filing?
ENSC closed at $0.36 before the filing and $0.39 on Nov 12, 2026 (+8.44%).
Other ENSC SEC filings
Get alerts when ENSC files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days